Top Markets
Coin of the day
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Rankning i aktier #6138
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
Aktiekurs
$154.04
Marknadsvärde
$2.21B
Förändring (1 dag)
-0.19%
Förändring (1 år)
172.88%
Land
US
Handel Palvella Therapeutics, Inc. (PVLA)

Kategori

Aktiekurshistorik för Palvella Therapeutics, Inc. (PVLA)
Högsta slutkurs: $151.69 den 2026-08-01

Lägsta slutkurs: $13.11 den 2024-12-01
Aktiekurshistorik för Palvella Therapeutics, Inc. från 2024 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 7.48%
2025 649.84%
2024 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$547.65 40.75%
US
$1.06K 49.04%
NL
$122.63 -12.65%
AU
$143.63 472.23%
US
$765.25 7.19%
CH